What companies are RPRX's competitors?

Royalty Pharma plc (RPRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does RPRX compare to its peers?

The peer comparison table on this page shows Royalty Pharma plc (RPRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does RPRX operate in?

Royalty Pharma plc (RPRX) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

RPRX

Royalty Pharma plc

NASDAQ·Medical, Pharmaceuticals · Healthcare

$58.72$0.30+0.51%

Pre-market·$58.72+0.00%

Market cap$25.26B·Market closed·Jul 22 8:00 PM UTC

Frequently Asked Questions About RPRX

What companies are RPRX's competitors?: Royalty Pharma plc (RPRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RPRX compare to its peers?: The peer comparison table on this page shows Royalty Pharma plc (RPRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RPRX operate in?: Royalty Pharma plc (RPRX) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

RPRX

Royalty Pharma plc

NASDAQ·Medical, Pharmaceuticals · Healthcare

$58.72$0.30+0.51%

Pre-market·$58.72+0.00%

Market cap$25.26B·Market closed·Jul 22 8:00 PM UTC

Peers


ROIV	Roivant Sciences Ltd.	$34.91	$25.1B
INCY	Incyte Corporation	$115.79	$23.1B
UTHR	United Therapeutics Corporation	$527.07	$22.4B
GMAB	Genmab A/S	$28.85	$17.7B
HOLX	Hologic, Inc.	$76.01	$17.0B
THC	Tenet Healthcare Corporation	$195.35	$16.8B
EXEL	Exelixis, Inc.	$54.98	$13.8B
FMS	Fresenius Medical Care AG & Co. KGaA	$24.30	$13.1B
SNN	Smith & Nephew plc	$29.94	$12.6B
SMMT	Summit Therapeutics Inc.	$14.74	$11.4B

Frequently Asked Questions About RPRX

What companies are RPRX's competitors?: Royalty Pharma plc (RPRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RPRX compare to its peers?: The peer comparison table on this page shows Royalty Pharma plc (RPRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RPRX operate in?: Royalty Pharma plc (RPRX) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.